WO1994023787A1 - Sampling balloon catheter - Google Patents

Sampling balloon catheter Download PDF

Info

Publication number
WO1994023787A1
WO1994023787A1 PCT/US1994/004402 US9404402W WO9423787A1 WO 1994023787 A1 WO1994023787 A1 WO 1994023787A1 US 9404402 W US9404402 W US 9404402W WO 9423787 A1 WO9423787 A1 WO 9423787A1
Authority
WO
WIPO (PCT)
Prior art keywords
balloon
surface
inflation
catheter
site
Prior art date
Application number
PCT/US1994/004402
Other languages
French (fr)
Inventor
David H. Rammler
Original Assignee
Rammler David H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US5204693A priority Critical
Priority to US08/052,046 priority
Application filed by Rammler David H filed Critical Rammler David H
Publication of WO1994023787A1 publication Critical patent/WO1994023787A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1002Balloon catheters characterised by balloon shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • A61B10/04Endoscopic instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B17/3205Excision instruments
    • A61B17/3207Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
    • A61B17/320725Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions with radially expandable cutting or abrading elements
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/22Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
    • A61B2017/22001Angioplasty, e.g. PCTA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B2017/320004Surgical cutting instruments abrasive
    • A61B2017/320008Scrapers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/32Surgical cutting instruments
    • A61B2017/320004Surgical cutting instruments abrasive
    • A61B2017/320012Brushes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0043Catheters; Hollow probes characterised by structural features
    • A61M2025/0057Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • A61M25/1038Wrapping or folding devices for use with balloon catheters

Abstract

Novel catheter balloons (10) are provided, having shaped surfaces (14, 16), which allow for delivery of drugs to a site in the vessel, provide for agents which allow for determination of blood flow and definition of the vessel walls, and sampling of the materials at the site for diagnosis. In addition, the balloons may be used for angioplasty.

Description

SAMPLING BALLOON CATHETER

INTRODUCTION

Technical Field

The field of this invention concerns catheters for use in angioplasty.

Background

Atherosclerosis is a major disease which affects millions of people. Despite the numerous efforts to reduce cholesterol intake and improve the food types which are ingested, large proportions of the population still maintain a heavy meat, heavy fat diet. While diet is believed to be a significant cause of the build-up of plaques in the vascular system, nevertheless the mechanism by which plagues build up in blood vessels is not well understood. The presence of platelets, foamy cells, lipoproteins, as well as other components, testifies to the complexity of the plaque formation process.

One of the techniques which is used to diminish the likelihood of clots at a vessel blockage is angioplasty. Angioplasty involves passing a balloon into the obstructed vessel and expanding the balloon at the obstruction. This results in an expansion of the vessel at the site of the balloon expansion, cracking of the plaque and compaction of the plaque, so as to open the vessel in this region. A number of problems are encountered using angioplasty, from inflammation of the expanded site to restenosis. In an unfortunately large proportion of the cases in which angioplasty is used, there is a closing of the vessel at the site of expansion. There is some belief that the balloon expansion activates cells in the region and results in an inflammatory response, which runs counter to the process which is being performed. Furthermore, it is believed that the nature of the lesion may vary widely, so that different treatments may be applicable for a particular lesion as compared to a different lesion. However, there is no way to know what the nature of the components are in the plaque, without surgery and removal of a portion of the vessel or a biopsy at the site of the lesion.

Other orifices or vessels require treatments, such as the urethra, anus, etc., where there is an interest in introducing a drug at a predetermined site, sampling physiological tissue at the site, or the like.

There is, therefore, substantial interest in providing techniques which will allow for therapeutic treatment at the site of the plaque during angioplasty and for determining the components of the plaque, particularly where such information may allow for improved therapies for sclerotic lesions as well as treatment of other pathological conditions in other orifices or vessels, where the site can be reached by a catheter.

SUMMARY OF THE INVENTION

Novel balloons for use with catheters are provided, where the balloons are shaped to provide for delivery of medicaments or other agents to a site of a lesion in a vessel and for sampling the plaque or other physiological material present at the site of the balloon expansion. The balloons are shaped to have ridges, where various agents may be included in the troughs between ridges as well as in the ridges, so that upon expansion of the balloon, the troughs expand and release and/or press the agents against the surface of the vessel . The surface of the balloon at one or more sites may provide for sampling of the lesion components, which will be retained by the balloon upon deflation and be carried with the balloon when removed from the vessel. In addition, the agent may include microbubble forming materials, so that the flow at the site of the balloon treatment can be determined using ultrasonic sound.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a perspective view of a deflated balloon according to this invention;

FIG. 2 is a cross-sectional view of the balloon of FIG. 1 when deflated;

FIG. 3 is a cross-sectional view of an inflated balloon according to FIG. 1;

FIG. 4 is a perspective view of an alternative embodiment of a balloon according to this invention;

FIG. 5 is a cross-sectional view of the embodiment of FIG. 4;

FIGS. 6, 7 and 8 are respectively cross-sectional views of the deflated and inflated balloon, and a perspective view, of an alternate embodiment of this invention;

FIGS. 9, 10 and 11 are respectively cross-sectional views of the deflated and inflated balloon and a perspective view of an alternate embodiment of this invention; and

FIGS. 12 and 13 are respectively deflated and inflated views of the cross-section of an alternative embodiment of this invention. DESCRIPTION OF THE SPECIFIC EMBODIMENTS

In accordance with the subject invention, balloons are provided in conjunction with balloon dilatation catheters for reaching a lesion in a physiological vessel, particularly of the cardiovascular system. The balloons are shaped so as to be able to carry agents with the balloons, which agents may be released upon inflation of the balloon. Furthermore, a portion of the surface of the balloon can serve to sample the surfaces with which the balloon interacts upon inflation, so as to retain plaque samples with the balloon upon deflation and retraction of the balloon from the vessels of the host. The balloons can be used with any of the conventional angioplasty devices or other devices, used in urology, proctology, etc. which allow for the control of movement of the balloon into the vessels of the host, inflation and deflation of the balloon and retrieval of the balloon from the host .

For the most part, the subject invention finds particular use in angioplasty. The angioplasty apparatus consists of a guiding catheter which is adapted to be inserted into the vessel of a patient . Also included is a guidewire which is adapted to the associated width of the catheter, guiding the catheter under the control of the operator so as to allow the movement of the end of the catheter carrying the balloon to the site for treatment. Finally, the catheter comprises a hollow tube which allows for inflation and deflation of the balloon. Various devices can be used, as described in U.S. Patent Nos. 5,040,548, 4,748,982 and 4,619,274. The particular device may vary depending upon what other functions are desired from the operation.

The characteristics of the balloon may vary. The thickness of the wall from balloon to balloon and within a single balloon may vary widely depending upon the particular shape of the balloon, and what portion of the balloon is to expand and the extent of expansion as compared to other portions, as well as the function the particular portion of the balloon is to serve. Thus, in many instances, the thickness of the wall will be varied, where thicker walls will be present, where little if any movement of the wall is desired, and thinner walls will be employed where the wall is to move and to expand in accordance with its function. For the most part, the balloons will be tubular having a much larger length than diameter and may be symmetrical or asymmetrical in its cross-section, usually symmetrical.

Various materials which are conventionally used for balloons may be employed in accordance with the subject invention, where the materials allow for the desired forming of the balloon. The balloon may be of any convenient polyolefin of varying densities, such as polyethylene, Teflon, silicon, acrylates and mixtures thereof. The uninflated diameter may range from about 0.5 to 1.5 millimeters, and may be inflatable to about 1.5 to 4 millimeters. The balloon will generally be at least about 0.5 centimeters in length and may be 2 centimeters or more in length, depending upon its purpose and an outside diameter of about 0.1 to 0.15 inch.

The balloon will be formed so as to provide for the desired conformation upon inflation. The balloon will normally not be inflated to a smooth cylinder, but rather have an uneven surface, involving troughs and peaks, usually extending substantially the full length of the balloon.

In order to achieve the desired shape, the thickness of the balloon may vary, so that the regions related to the trough may be thicker than the regions related to the peaks and, therefore, be substantially less extensible or flexible than the regions which are to be expanded to provide the peaks or ridges or vice versa. In addition, regions of the balloon surface may be roughened, provided with narrow low spines, ridges, protuberances or wrinkles, or roughened areas, where the elevation of the projections may be as small as 0.01 millimeter and as large as about 0.05 millimeter. These elevations may be perpendicular to or parallel to the long axis of the balloon or have no particular common orientation to the long axis of the balloon.

The balloons may be inflated with any convenient fluid, particularly liquids, which can be delivered and recovered through conventional catheter devices which feed the fluid into the balloon. Upon inflation, the balloon can provide for individual projections or knobs, where the knobs may protrude from the substantially cylindrical surface of the balloon in a symmetrical or asymmetrical or relatively random manner. Alternatively, one may have ridges extending from the cylindrical portion of the balloon, which may also be disposed symmetrically or asymmetrically.

The deflated balloon may be relatively smooth and uniform about its external surface or may already form to a substantially lesser degree the various protuberances which will occur upon inflation. By having the protuberances existing to a minor degree for inflation, the balloon will be easier to inflate and one may be assured that the areas which are to extend outwardly from the surface are more likely to be inflated.

The subject balloons may not only be used for therapeutic purposes, such as angioplasty, but they also may be used to deliver drugs. A portion on substantially all of the surface of the balloon may be coated, in whole or in part, with various therapeutic agents, which may adhere to the surface of the balloon as a result of adsorption, adhesion, use of an adhesive agent, use of protective polymers which will erode with time, so as to release the drug, in accordance with the time frame of the association of the balloon with the site to be treated, and the like. A concavity may be provided at the front of the balloon as a container for a therapeutic agent. A wide variety of drugs can be used, such as anti-inflammatory steroids, anticlotting agents, cell proliferation inhibitors, etc. In addition, various physiologically acceptable adhesives may be employed in conjunction with the drugs, where the adhesives will be dissolved or eroded upon inflation of the balloon. Illustrative adhesives include PVC, acrylates, complex carbohydrates, etc. By introducing drugs onto the surface of the balloon, particularly in troughs, when the balloon is deflated, the balloon may be wrinkled, where the drugs will be protected in the wrinkle from release. Upon inflation, and expansion of the protuberances, the drug will then be released and pressed into the vessel wall, as well as exposed to the flow of blood, or other physiological fluid, which will move the drug from the surface into contact with the vessel wall.

Also, the roughened surface and protuberance will be involved with pressing and rubbing against the vessel wall . Where plaques are present, the plaque material which is soft, will be captured on the surface of the balloon by the indentations in the balloon, so that upon deflation, the particulates of plaque or other loose material associated with the vessel wall will be captured in the balloon. In this manner, when the balloon is retracted, the balloon will carry with it samples of the material it has encountered upon inflation. These materials may be analyzed to determine the nature of the plaque, which may then be related to particular indications or diseased states. Thus, the balloon may not only serve to provide therapy, but may also serve to analyze the nature of the injury and compositions associated with the injury.

The channels created upon inflation will allow for movement of blood through the vessel to varying degrees depending on the design of the balloon. If blood or other fluid stoppage is desired, one can form relatively narrow channels or have a fairly smooth outer surface. If flow in the vessel is desired, their channels can be formed which allow for fluid flow while compacting the vessel wall with the protuberances. Since the balloon will have an uneven surface, plaque present on the vessel wall will not be compacted evenly. One may vary the design, to where the protuberance will have a fairly flat surface at the top and each protuberance will extend a distance from its central axis, so that the protuberances may provide a substantially continuous cylindrical surface pressing against the plaque. In this way, one can only achieve the purposes described above, as well as provide for angioplasty, so as to clear the vessel from blockage.

Instead of or in addition to drugs, the balloon may also serve to provide for various agents which will allow for determining characteristics of interest associated with the vessel. For example, agents may be provided which may be released from the balloon upon inflation which will form microbubbles . Various microbubble agents have been taught in the literature, such as the use of bovine serum albumin, gelatin coated microbubbles, fused saccharide encapsulating pressurized microbubbles, microparticles which trap bubbles, microbubbles within human albumin shells and the like. These particles may be applied to the surface of the balloon, which will be released upon inflation of the balloon, providing microbubbles in the vessel. See, for example, U.S. Patent Nos. 4,466,442 and 4,718,433. The microbubbles may then be used with ultrasonic analysis to determine the rate of flow of blood in the vessel, as well as to provide contrast to detect the walls of the vessel surrounding the microbubbles. Instead of microbubbles, one may provide for fluorescent agents, where the vessel is near the skin wall, or other agents, such as short-lived radionuclides e.g. Tc, which may provide for better definition of the vessel walls.

Where one wishes to also provide for balloon angioplasty, various structures and techniques may be employed. For example, one may inflate the balloon stepwise, so that in a first step, one creates an uneven surface by using an intermediate pressure to provide for release of drug, but without uniform pressure on the vessel . One can then increase the pressure in the balloon to provide for a fairly uniform circumference, where there is substantially uniform interaction with the vessel surface, so as to compress the plaque and create cracks in the plaque, where a therapeutic drug included on the balloon can be compressed into the crack. The pressure could then be reduced stepwise or in a uniform manner, where plaque particulates would be captured by the hollows or depressions in the balloon.

For further understanding of the subject invention, the drawings will now be considered.

In FIG. 1, one embodiment of the invention is depicted, where the balloon 10 is connected to a liquid supply system by conduit 12. The balloon is generally symmetrical, having roughened ridges 14 symmetrically disposed about the surface of the balloon. The balloon is mildly wrinkled having low ridges 16 and troughs 18 between the ridges 16. A frontal protuberance 20 is present. The balloon has a concavity or small pocket at the front, so that a small finger extends inwardly. This cavity can serve as a container for a therapeutic or other agent. Upon inflation, the finger will move outwardly releasing the drug at the site of interest . In FIG. 2, a cross-section of balloon 10 is shown with ridges 16 and troughs 18. The troughs 18 have a somewhat thicker wall than the protuberances or ridges 16, so that upon inflation, they do not stretch as much and allow for the formation of the ridges 16. On the surface of the ridges, are low elevations or spines 22 which serve for the roughened surface 14. Between the spines 22, there may be included various agents. Alternatively, or in conjunction with the agents present between the spines 22, may be agents coated onto trough 18.

As shown in FIG. 3, the trough 18 may have spines 22, which may serve to contain various agents. The outer surface 26 of protuberances 16 will serve to press the spines 22 against the vessel wall, resulting in rubbing against the vessel wall and removing material from the vessel wall . This material will then be confined between the spines and will be captured upon deflation of the balloon, so that upon retraction, the material will be contained between the spines on the surface of the balloon.

In FIG. 3, the protuberances have roughened ridges 14 which will press against the vessel wall and remove small particles from the vessel wall, to be retained on the surface 28. Also, spines which may act as bristles provide roughened a surface 14 which serves to capture and retain the plaque particles. In addition, a catheter can be provided to be capable of rotating the balloon, so that the protuberances will move against the vessel wall, scraping the vessel wall, opening the vessel and removing the plaque and/or other accumulation on the vessel wall. A sound imaging probe (not shown) may be placed at the center of the balloon. These probes are described by and available from Endosonics and Civis Corporation. This imaging tool can be used to determine the site of the balloon and to visualize the internal diameter of the restricted site.

In FIGS. 4 and 5, an alternative embodiment of the subject invention is shown where the balloon 40 has conduit 42 for introducing a fluid into the balloon. In this embodiment, the cylindrical portion of the balloon 44 has protrusion 46, analogous to protrusion 20 of the balloon in FIG. 1. Criss¬ crossing channels 48 are provided, which upon expansion will be pressed against the vessel wall and will result in material on the vessel wall being deposited in the channels

48. Upon deflation, this material will be captured within the channel so as to be retained upon removal of the balloon from the vessel. A cross-section of balloon 40 is shown in FIG. 5, with channels 48 separated by the wall of the balloon 50. In FIG. 6, there is shown an alternative embodiment in cross-section, where the balloon 60 has lumen 62 and internal walls 64, which are thicker and will not inflate as much as the ears shaped projections 66. The projections 66 have ears 68 which overlap ears of adjacent projections. Upon inflation, FIG.7, the projections will expand so as to have a substantially cylindrical outer surface, where the ears 68 will be substantially contiguous, one with the other, to form a relatively uniform cylinder while still providing internal channels 70. In this way, one may provide for a substantially uniform compression against the vessel wall, while still providing for delivery of drugs and capture of plaque particles.

In FIG. 8 is shown the deflated balloon 72, having a front 74 which includes the pocket, not shown. The ears shaped projections 66 extend the length of the balloon 72. A tube 76 provides means for connection to a guiding catheter and fluid supply.

FIGS. 9, 10 and 11 provide an alternative balloon 80, when the deflated balloon 80 has a plurality of fingers 82, where the walls are of similar thickness. Drug can be ratined between the fingers 82. Upon inflation, as shown in FIG. 10, the outer wall 84 becomes relatively smooth with some depression forming channels 81. Drug on the walls is pressed into the plaque and plaque can be captured between the fingers 82 upon deflation. The deflated balloon has means for connection to a guiding catheter and fluid supply 88. The fingers 82 appear as ridge 90 extending the length of the balloon 80.

In FIGS. 12 and 13, the balloon 100 has curved on floppy fingers 102, which surround lumen 104 and flop over each other, so as to form covered channels 106. While deflated, the balloon results in protected channels which can contain various agents. Upon expansion, the balloon forms an uneven surface 107 with relatively shallow channels 110, which can serve the same purpose as the channels in the other embodiments and can function in an analogous manner.

In accordance with the subject invention, novel catheter balloons are provided which allow for a number of advantages as compared to presently existing balloons. The balloons provide for the administration of drugs at the site of inflation and collection of sample at the site of inflation. During deflation, the drug is substantially contained in wrinkles or folds of the balloon, so that it can be retained during its movement through the vessels to the site for therapeutic treatment. In addition, sources of microbubbles can be used, so as to permit detection of blood flow and to provide for greater contrast in identifying the vessel wall. Other agents may also be employed to define the vessel wall. By virtue of contact with the vessel wall, samples of material with which the subject balloon is in contact will be retained by the balloon. Upon deflation, the samples will be protected from loss during the travel of the balloon upon retraction. The samples may then be used in a variety of diagnostic techniques, to further understand the diseased site to which the balloon has been introduced.

All publications and patent applications cited in this specification are herein incorporated by reference as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference.

Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A catheter balloon comprising: means for inflation of said balloon; an uneven surface comprising depressed and elevated regions upon inflation extending substantially the full length of said balloon, said surface being roughened at least in part to retain a solid drug, particulate plaque, or other physiological material .
2. A catheter balloon according to Claim 1, wherein said balloon comprises alternating regions parallel to the long axis of said balloon catheter resulting in troughs and ridges upon inflation.
3. A catheter balloon according to Claim 2, wherein said trough regions have thicker walls than said ridge regions .
4. A catheter balloon according to Claim 2, wherein said ridge regions partially extend above the surface of said trough regions and have a slack surface while deflated.
5. A catheter balloon according to Claim 1, wherein a portion of at least said ridges has a roughened surface.
6. A catheter balloon according to Claim 1, wherein at least a portion of said balloon is in contact with a drug.
7. A catheter balloon according to Claim 1, having a plurality of protuberances upon inflation.
8. A catheter balloon comprising: an uneven surface comprising trough and ridge regions upon inflation extending substantially the full length of said balloon, substantially parallel to the long axis of said balloon, said surface being roughened at least in part to be capable of retaining a solid drug,particulate plaque or other physiological material, said balloon having an inflated diameter to length ratio in the range of about 1:2-20; and means for inflation of said balloon.
9. A catheter balloon according to Claim 8, wherein at least one of said ridges has a roughened surface.
10. A method for treating and/or diagnosing a lesion, said method comprising; introducing into a cardiovascular vessel a catheter balloon comprising: means for inflation of said balloon; and an uneven surface comprising depressed and elevated regions upon inflation extending substantially the full length of said balloon, said surface being roughened at least in part to retain a solid drug, microbubble producing agent, particulate plaque or other physiological material; inflating said balloon at a site suspected of comprising a lesion, whereby any lesion present at said site is at least partially compressed and any drug or microbubble agent on said balloon is released, and plaque particles or other physiological material are restrained in said depressed regions; deflating said catheter balloon enclosing said plaque particles or other physiological material; and retracting said catheter balloon from said site retaining said plaque particles or other physiological material.
11. A method according to Claim 10, wherein a drug is present on said balloon surface.
12. A method according to Claim 10, wherein a microbubble agent is present on said balloon surface and including the additional steps of applying sound to said site to detect the flow of blood at said site or define the surface of said lesion.
13. A method according to Claim 10, wherein said catheter balloon is inflated stepwise, wherein sufficient pressure is applied to said balloon to compress said lesion substantially uniformly.
14. A method according to Claim 10, wherein said catheter balloon is rotated after inflation to compress said lesion.
PCT/US1994/004402 1993-04-22 1994-04-21 Sampling balloon catheter WO1994023787A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US5204693A true 1993-04-22 1993-04-22
US08/052,046 1993-04-22

Publications (1)

Publication Number Publication Date
WO1994023787A1 true WO1994023787A1 (en) 1994-10-27

Family

ID=21975092

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1994/004402 WO1994023787A1 (en) 1993-04-22 1994-04-21 Sampling balloon catheter

Country Status (1)

Country Link
WO (1) WO1994023787A1 (en)

Cited By (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1000106C2 (en) * 1995-04-10 1996-10-11 Cordis Europ Balloon catheter with a lobed balloon and method of manufacturing thereof.
EP0753322A2 (en) * 1995-07-10 1997-01-15 Interventional Technologies Inc Catheter for injecting fluid medication into an arterial wall
US5713863A (en) * 1996-01-11 1998-02-03 Interventional Technologies Inc. Catheter with fluid medication injectors
US5873852A (en) * 1995-07-10 1999-02-23 Interventional Technologies Device for injecting fluid into a wall of a blood vessel
US6102904A (en) * 1995-07-10 2000-08-15 Interventional Technologies, Inc. Device for injecting fluid into a wall of a blood vessel
AU723489B2 (en) * 1995-10-10 2000-08-31 Interventional Technologies Inc. Catheter with fluid medication injectors
US6129706A (en) * 1998-12-10 2000-10-10 Janacek; Jaroslav Corrugated catheter balloon
US6210392B1 (en) 1999-01-15 2001-04-03 Interventional Technologies, Inc. Method for treating a wall of a blood vessel
US6258099B1 (en) 1999-03-31 2001-07-10 Scimed Life Systems, Inc. Stent security balloon/balloon catheter
EP1165176A1 (en) * 1999-01-15 2002-01-02 Interventional Technologies Inc Inflatable medical device maintaining injectors for delivery to a localized region
EP1169970A1 (en) * 2000-07-04 2002-01-09 Transgene S.A. Device for the administration of a composition in a conduit of a human or animal body
EP1365182A1 (en) * 2002-05-21 2003-11-26 Keld Saxenfelt An inflatable, flexible device
WO2004006976A1 (en) * 2002-07-12 2004-01-22 Cook Incorporated Coated medical device
US6695830B2 (en) 1999-01-15 2004-02-24 Scimed Life Systems, Inc. Method for delivering medication into an arterial wall for prevention of restenosis
US6736841B2 (en) 1999-03-31 2004-05-18 Scimed Life Systems, Inc. Textured and/or marked balloon for stent delivery
EP1453414A2 (en) * 2001-12-13 2004-09-08 Avantec Vascular Corporation Inflatable members having concentrated force regions
US20050277877A1 (en) * 2001-03-26 2005-12-15 Tom Motsenbocker Balloon technology
WO2006003447A1 (en) * 2004-07-07 2006-01-12 Colonix Limited Colorectal cell sampling device
WO2006016938A1 (en) * 2004-07-13 2006-02-16 Boston Scientific Limited Balloon folding design and method and apparatus for making balloons
EP1642612A2 (en) * 1995-04-10 2006-04-05 Cordis Europa N.V. Balloon catheter with lobated balloon and method for manufacturing such a catheter
WO2006124398A2 (en) 2005-05-11 2006-11-23 Angioscore, Inc. Methods and systems for delivering substances into luminal walls
EP1825824A1 (en) * 2006-02-24 2007-08-29 National University of Ireland, Galway Minimally invasive intravascular treatment device
DE102007003184A1 (en) 2007-01-22 2008-07-24 Orlowski, Michael, Dr. A method for loading of structured surfaces
DE202009006632U1 (en) 2009-05-07 2009-07-16 Sellin, Lothar Coating of medical surfaces
WO2009111712A1 (en) * 2008-03-06 2009-09-11 Boston Scientific Scimed, Inc. Balloon catheter devices with folded balloons
EP2116178A1 (en) * 2008-05-09 2009-11-11 Sapi Med S.p.A. Medical device for anorectal diagnostic analyses
EP2147695A1 (en) * 2008-07-23 2010-01-27 Abbott Laboratories Vascular Enterprises Limited Balloon of a balloon catheter
WO2010011843A1 (en) * 2008-07-25 2010-01-28 Cook Incorporated Balloon catheter and method for making the same
US7750041B2 (en) 2001-03-26 2010-07-06 Bayer Schering Pharma Aktiengesellschaft Preparation for the prophylaxis of restenosis
WO2010102796A2 (en) 2009-03-10 2010-09-16 Phenox Gmbh Device for applying active ingredients to the wall of a body vessel
EP2243501A1 (en) 2009-04-24 2010-10-27 Eurocor Gmbh Shellac and paclitaxel coated catheter balloons
US20100312182A1 (en) * 2009-06-04 2010-12-09 Nina Adden Structured drug-eluting balloon catheter
EP2269664A2 (en) 2007-01-21 2011-01-05 Hemoteq AG Medical product for treating closures of bodily passages and preventing reclosures
EP2285443A2 (en) * 2008-05-01 2011-02-23 Bayer Schering Pharma AG Catheter balloon drug adherence techniques and methods
WO2011046902A1 (en) * 2009-10-14 2011-04-21 Boston Scientific Scimed, Inc. Balloon catheter with shape memory sheath for delivery of therapeutic agent
WO2011044889A1 (en) 2009-10-16 2011-04-21 Hemoteq Ag Use of compositions to coat catheter balloons and coated catheter balloons
US7942661B2 (en) 2007-07-18 2011-05-17 Boston Scientific Scimed, Inc. Bifurcated balloon folding method and apparatus
WO2011061295A1 (en) * 2009-11-19 2011-05-26 Blue Medical Devices Bv Narrow profile composition-releasing expandable medical balloon catheter
US7955350B2 (en) 2003-01-21 2011-06-07 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
US8008395B2 (en) 2005-09-27 2011-08-30 Boston Scientific Scimed, Inc. Organic-inorganic hybrid particle material and polymer compositions containing same
EP2380604A1 (en) 2010-04-19 2011-10-26 InnoRa Gmbh Improved coating formulations for scoring or cutting balloon catheters
EP2380605A1 (en) 2010-04-19 2011-10-26 InnoRa Gmbh Improved formulations for drug-coated medical devices
WO2011131678A1 (en) 2010-04-19 2011-10-27 Innora Gmbh Limus-coated medical devices
WO2011147407A2 (en) 2010-05-27 2011-12-01 Hemoteq Ag Balloon catheter coated with an anti-restenotic active ingredient and a molecular dispersion agent that promotes transport
US8080026B2 (en) 2003-01-21 2011-12-20 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
US8088100B2 (en) 2006-10-20 2012-01-03 Boston Scientific Scimed, Inc. Reinforced rewrappable balloon
US8177743B2 (en) 1998-05-18 2012-05-15 Boston Scientific Scimed, Inc. Localized delivery of drug agents
US8257305B2 (en) 2002-09-20 2012-09-04 Bayer Pharma Aktiengesellschaft Medical device for dispensing medicaments
US20120245616A1 (en) * 2001-11-09 2012-09-27 Farnan Robert C Balloon Catheter With Non-Deployable Stent
DE102011100122A1 (en) 2011-04-26 2012-10-31 Eurocor Gmbh Catheter balloon coated with rapamycin and shellac
WO2013007273A1 (en) 2011-07-08 2013-01-17 Cardionovum Sp.Z.O.O. Balloon surface coating
WO2013015941A1 (en) * 2011-07-26 2013-01-31 Medtronic Vascular Inc. Textured dilatation balloon
US20130066268A1 (en) * 2006-02-09 2013-03-14 B. Braun Melsungen Ag Coating Method for a Folded Balloon
WO2013053809A1 (en) 2011-10-14 2013-04-18 Innora Gmbh Improved formulations for drug-coated medical devices
WO2013059272A1 (en) * 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Atherectomy positioning device
WO2013092416A1 (en) 2011-12-23 2013-06-27 Innora Gmbh Drug-coated medical devices
WO2013116560A1 (en) * 2012-01-31 2013-08-08 The Trustees Of Columbia University In The City Of New York Tissue sampling devices, methods, and systems
WO2014008875A1 (en) 2012-07-12 2014-01-16 Cardionovum Gmbh Catheter balloon, method for producing a coated catheter balloon and use of the pharmacological active ingredient
EP2713890A1 (en) * 2011-05-26 2014-04-09 ADN International, LLC Expandable device for tissue collection from an aerodigestive body lumen
WO2014125465A2 (en) 2013-02-13 2014-08-21 Prendergast Thomas Patrick Method for loading dilatable catherer balloons and dilatation catheters obtained therefrom
WO2014177221A1 (en) 2013-05-02 2014-11-06 Cardionovum Gmbh Balloon surface coating
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
WO2015089422A1 (en) * 2013-12-12 2015-06-18 Case Western Reserve University Device for collecting a biological sample
US9125968B2 (en) * 2005-03-30 2015-09-08 Boston Scientific Scimed, Inc. Polymeric/ceramic composite materials for use in medical devices
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
US9351756B2 (en) 2010-09-21 2016-05-31 Angioscore, Inc. Method and system for treating valve stenosis
US9375328B2 (en) 2001-11-09 2016-06-28 Angioscore, Inc. Balloon catheter with non-deployable stent
CN105943117A (en) * 2012-01-15 2016-09-21 小麦公司 Device and method for removing occlusions in a biological vessel
EP3115077A1 (en) * 2015-07-06 2017-01-11 Terumo Kabushiki Kaisha Balloon catheter and method for manufacturing balloon
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
US10117668B2 (en) 2013-10-08 2018-11-06 The Spectranetics Corporation Balloon catheter with non-deployable stent having improved stability
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2701559A (en) * 1951-08-02 1955-02-08 William A Cooper Apparatus for exfoliating and collecting diagnostic material from inner walls of hollow viscera
US3664328A (en) * 1971-04-28 1972-05-23 Henry Dinwoodey Moyle Jr Cancer test specimen gathering device
US5049131A (en) * 1989-05-31 1991-09-17 Ashridge Ag Balloon catheter
US5102402A (en) * 1991-01-04 1992-04-07 Medtronic, Inc. Releasable coatings on balloon catheters
US5108414A (en) * 1989-11-09 1992-04-28 C. R. Bard, Inc. Techniques for dilating obstructed lumens and other luminal procedures
US5192290A (en) * 1990-08-29 1993-03-09 Applied Medical Resources, Inc. Embolectomy catheter
US5196024A (en) * 1990-07-03 1993-03-23 Cedars-Sinai Medical Center Balloon catheter with cutting edge
US5250070A (en) * 1991-05-28 1993-10-05 Parodi Juan C Less traumatic angioplasty balloon for arterial dilatation

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2701559A (en) * 1951-08-02 1955-02-08 William A Cooper Apparatus for exfoliating and collecting diagnostic material from inner walls of hollow viscera
US3664328A (en) * 1971-04-28 1972-05-23 Henry Dinwoodey Moyle Jr Cancer test specimen gathering device
US5049131A (en) * 1989-05-31 1991-09-17 Ashridge Ag Balloon catheter
US5108414A (en) * 1989-11-09 1992-04-28 C. R. Bard, Inc. Techniques for dilating obstructed lumens and other luminal procedures
US5196024A (en) * 1990-07-03 1993-03-23 Cedars-Sinai Medical Center Balloon catheter with cutting edge
US5192290A (en) * 1990-08-29 1993-03-09 Applied Medical Resources, Inc. Embolectomy catheter
US5102402A (en) * 1991-01-04 1992-04-07 Medtronic, Inc. Releasable coatings on balloon catheters
US5250070A (en) * 1991-05-28 1993-10-05 Parodi Juan C Less traumatic angioplasty balloon for arterial dilatation

Cited By (164)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1000106C2 (en) * 1995-04-10 1996-10-11 Cordis Europ Balloon catheter with a lobed balloon and method of manufacturing thereof.
EP0737488A1 (en) * 1995-04-10 1996-10-16 Cordis Europa N.V. Balloon catheter with lobated balloon and method for manufacturing such a catheter
EP1642612A3 (en) * 1995-04-10 2006-04-12 Cordis Europa N.V. Balloon catheter with lobated balloon and method for manufacturing such a catheter
US5759172A (en) * 1995-04-10 1998-06-02 Cordis Corporation Balloon catheter with lobed balloon and method for manufacturing such a catheter
EP1642612A2 (en) * 1995-04-10 2006-04-05 Cordis Europa N.V. Balloon catheter with lobated balloon and method for manufacturing such a catheter
EP0753322A2 (en) * 1995-07-10 1997-01-15 Interventional Technologies Inc Catheter for injecting fluid medication into an arterial wall
US5681281A (en) * 1995-07-10 1997-10-28 Interventional Technologies, Inc. Catheter with fluid medication injectors
EP0753322A3 (en) * 1995-07-10 1997-03-26 Interventional Technologies Catheter for injecting fluid medication into an arterial wall
US5873852A (en) * 1995-07-10 1999-02-23 Interventional Technologies Device for injecting fluid into a wall of a blood vessel
US6102904A (en) * 1995-07-10 2000-08-15 Interventional Technologies, Inc. Device for injecting fluid into a wall of a blood vessel
US5746716A (en) * 1995-07-10 1998-05-05 Interventional Technologies Inc. Catheter for injecting fluid medication into an arterial wall
AU723489B2 (en) * 1995-10-10 2000-08-31 Interventional Technologies Inc. Catheter with fluid medication injectors
US5713863A (en) * 1996-01-11 1998-02-03 Interventional Technologies Inc. Catheter with fluid medication injectors
US8177743B2 (en) 1998-05-18 2012-05-15 Boston Scientific Scimed, Inc. Localized delivery of drug agents
US8262613B2 (en) 1998-05-18 2012-09-11 Boston Scientific Scimed, Inc. Localized delivery of drug agents
US8574191B2 (en) 1998-05-18 2013-11-05 Boston Scientific Scimed, Inc. Localized delivery of drug agents
US6129706A (en) * 1998-12-10 2000-10-10 Janacek; Jaroslav Corrugated catheter balloon
US6695830B2 (en) 1999-01-15 2004-02-24 Scimed Life Systems, Inc. Method for delivering medication into an arterial wall for prevention of restenosis
EP1165176A1 (en) * 1999-01-15 2002-01-02 Interventional Technologies Inc Inflatable medical device maintaining injectors for delivery to a localized region
EP1165176A4 (en) * 1999-01-15 2006-12-13 Interventional Technologies Inflatable medical device maintaining injectors for delivery to a localized region
US6210392B1 (en) 1999-01-15 2001-04-03 Interventional Technologies, Inc. Method for treating a wall of a blood vessel
US8066690B2 (en) 1999-01-15 2011-11-29 Boston Scientific Scimed, Inc. Method for delivering medication into an arterial wall for prevention of restenosis
US6258099B1 (en) 1999-03-31 2001-07-10 Scimed Life Systems, Inc. Stent security balloon/balloon catheter
US6676667B2 (en) 1999-03-31 2004-01-13 Scimed Life Systems, Inc. Stent security balloon/balloon catheter
US7056323B2 (en) 1999-03-31 2006-06-06 Scimed Life Systems, Inc. Stent security balloon/balloon catheter
US6736841B2 (en) 1999-03-31 2004-05-18 Scimed Life Systems, Inc. Textured and/or marked balloon for stent delivery
US6786889B1 (en) 1999-03-31 2004-09-07 Scimed Life Systems, Inc Textured and/or marked balloon for stent delivery
EP1169970A1 (en) * 2000-07-04 2002-01-09 Transgene S.A. Device for the administration of a composition in a conduit of a human or animal body
US9694162B2 (en) 2000-10-31 2017-07-04 Cook Medical Technologies Llc Coated medical device
US8974522B2 (en) 2000-10-31 2015-03-10 Cook Medical Technologies Llc Coated medical device
US9814865B2 (en) 2000-10-31 2017-11-14 Cook Medical Technologies Llc Coated medical device
US20050277877A1 (en) * 2001-03-26 2005-12-15 Tom Motsenbocker Balloon technology
US9066990B2 (en) 2001-03-26 2015-06-30 Bayer Intellectual Property Gmbh Preparation for restenosis prevention
US7750041B2 (en) 2001-03-26 2010-07-06 Bayer Schering Pharma Aktiengesellschaft Preparation for the prophylaxis of restenosis
US8389043B2 (en) 2001-03-26 2013-03-05 Bayer Pharma Aktiengesellschaft Preparation for restenosis prevention
US20120245616A1 (en) * 2001-11-09 2012-09-27 Farnan Robert C Balloon Catheter With Non-Deployable Stent
US10086178B2 (en) 2001-11-09 2018-10-02 Angioscore, Inc. Balloon catheter with non-deployable stent
US9375328B2 (en) 2001-11-09 2016-06-28 Angioscore, Inc. Balloon catheter with non-deployable stent
EP1453414A2 (en) * 2001-12-13 2004-09-08 Avantec Vascular Corporation Inflatable members having concentrated force regions
EP1453414A4 (en) * 2001-12-13 2008-07-23 Avantec Vascular Corp Inflatable members having concentrated force regions
EP1365182A1 (en) * 2002-05-21 2003-11-26 Keld Saxenfelt An inflatable, flexible device
WO2003098082A1 (en) * 2002-05-21 2003-11-27 Keld Saxenfelt An inflatable, flexible device for use as an expandable closure device, and a method of producing said device
EP2324867A1 (en) * 2002-07-12 2011-05-25 Cook Incorporated Angioplasty balloons drug-coated in an expanded condition
WO2004006976A1 (en) * 2002-07-12 2004-01-22 Cook Incorporated Coated medical device
EP2324866A3 (en) * 2002-07-12 2011-10-26 Cook Incorporated Angioplasty balloons drug-coated in an expanded condition
EP2851097A3 (en) * 2002-07-12 2015-06-10 Cook Medical Technologies LLC Drug-coated angioplasty balloons
AU2003256540B2 (en) * 2002-07-12 2008-12-11 Cook Medical Technologies Llc Coated medical device
US7803149B2 (en) 2002-07-12 2010-09-28 Cook Incorporated Coated medical device
AU2009200537B2 (en) * 2002-07-12 2011-06-09 Cook Medical Technologies Llc Coated medical device
US9302080B2 (en) 2002-09-20 2016-04-05 Bayer Intellectual Property Gmbh Medical device for dispersing medicaments
US9216273B2 (en) 2002-09-20 2015-12-22 Bayer Intellectual Property Gmbh Medical device for dispersing medicaments
EP2216055B1 (en) 2002-09-20 2017-07-26 Bayer Intellectual Property GmbH medical device for dispensing medicaments
EP1539267B1 (en) 2002-09-20 2016-08-31 Bayer Intellectual Property GmbH Medical device for dispensing medicaments
US8257305B2 (en) 2002-09-20 2012-09-04 Bayer Pharma Aktiengesellschaft Medical device for dispensing medicaments
US9649476B2 (en) 2002-09-20 2017-05-16 Bayer Intellectual Property Gmbh Medical device for dispersing medicaments
US9687635B2 (en) 2002-09-20 2017-06-27 Bayer Intellectual Property Gmbh Medical device for dispersing medicaments
US9216272B2 (en) 2002-09-20 2015-12-22 Bayer Intellectual Property Gmbh Medical device for dispersing medicaments
US8439868B2 (en) 2002-09-20 2013-05-14 Bayer Pharma AG Medical device for dispersing medicaments
US9962529B2 (en) 2003-01-21 2018-05-08 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
US7955350B2 (en) 2003-01-21 2011-06-07 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
US8080026B2 (en) 2003-01-21 2011-12-20 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
US8454636B2 (en) 2003-01-21 2013-06-04 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
US8721667B2 (en) 2003-01-21 2014-05-13 Angioscore, Inc. Apparatus and methods for treating hardened vascular lesions
NO339684B1 (en) * 2004-07-07 2017-01-23 Colonix Ltd Colorectal cell sampling device
WO2006003447A1 (en) * 2004-07-07 2006-01-12 Colonix Limited Colorectal cell sampling device
US8992438B2 (en) 2004-07-07 2015-03-31 Colonix Limited Colorectal cell sampling device
EA011367B1 (en) * 2004-07-07 2009-02-27 Колоникс Лимитед Device for colorectal cell sampling
JP2008506454A (en) * 2004-07-13 2008-03-06 ボストン サイエンティフィック リミテッド Method and apparatus for manufacturing a balloon folding design and balloon
EP3064243A1 (en) * 2004-07-13 2016-09-07 Boston Scientific Limited Balloon folding design and method and apparatus for making balloons
WO2006016938A1 (en) * 2004-07-13 2006-02-16 Boston Scientific Limited Balloon folding design and method and apparatus for making balloons
US7972351B2 (en) 2004-07-13 2011-07-05 Boston Scientific Scimed, Inc. Balloon folding design and method and apparatus for making balloons
US9125968B2 (en) * 2005-03-30 2015-09-08 Boston Scientific Scimed, Inc. Polymeric/ceramic composite materials for use in medical devices
US10342960B2 (en) 2005-05-11 2019-07-09 Angioscore, Inc. Methods and systems for delivering substances into luminal walls
EP1885431A4 (en) * 2005-05-11 2010-06-02 Angioscore Inc Methods and systems for delivering substances into luminal walls
EP1885431A2 (en) * 2005-05-11 2008-02-13 Angioscore Inc. Methods and systems for delivering substances into luminal walls
WO2006124398A2 (en) 2005-05-11 2006-11-23 Angioscore, Inc. Methods and systems for delivering substances into luminal walls
US9586031B2 (en) 2005-05-11 2017-03-07 Angioscore, Inc. Methods and systems for delivering substances into luminal walls
US10076641B2 (en) 2005-05-11 2018-09-18 The Spectranetics Corporation Methods and systems for delivering substances into luminal walls
US8008395B2 (en) 2005-09-27 2011-08-30 Boston Scientific Scimed, Inc. Organic-inorganic hybrid particle material and polymer compositions containing same
US20130066268A1 (en) * 2006-02-09 2013-03-14 B. Braun Melsungen Ag Coating Method for a Folded Balloon
EP3485920A1 (en) 2006-02-09 2019-05-22 B. Braun Melsungen AG Coating method for a folded balloon
US8658239B2 (en) * 2006-02-09 2014-02-25 B. Braun Melsungen Ag Coating method for a folded balloon
EP3150236A1 (en) 2006-02-09 2017-04-05 B. Braun Melsungen AG Coating method for a folded balloon
EP1825824A1 (en) * 2006-02-24 2007-08-29 National University of Ireland, Galway Minimally invasive intravascular treatment device
US8088100B2 (en) 2006-10-20 2012-01-03 Boston Scientific Scimed, Inc. Reinforced rewrappable balloon
EP2269664A2 (en) 2007-01-21 2011-01-05 Hemoteq AG Medical product for treating closures of bodily passages and preventing reclosures
EP2491962A1 (en) 2007-01-21 2012-08-29 Hemoteq AG Medical product for treating closures of bodily passages and preventing reclosures
DE102007003184A1 (en) 2007-01-22 2008-07-24 Orlowski, Michael, Dr. A method for loading of structured surfaces
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
US7942661B2 (en) 2007-07-18 2011-05-17 Boston Scientific Scimed, Inc. Bifurcated balloon folding method and apparatus
WO2009111712A1 (en) * 2008-03-06 2009-09-11 Boston Scientific Scimed, Inc. Balloon catheter devices with folded balloons
EP2285443B1 (en) * 2008-05-01 2016-11-23 Bayer Intellectual Property GmbH Catheter balloon drug adherence techniques and methods
EP2285443A2 (en) * 2008-05-01 2011-02-23 Bayer Schering Pharma AG Catheter balloon drug adherence techniques and methods
EP2116178A1 (en) * 2008-05-09 2009-11-11 Sapi Med S.p.A. Medical device for anorectal diagnostic analyses
US8932340B2 (en) 2008-05-29 2015-01-13 Boston Scientific Scimed, Inc. Bifurcated stent and delivery system
US20110295201A1 (en) * 2008-07-23 2011-12-01 Nicolas Degen Balloon of a balloon catheter
WO2010009785A1 (en) * 2008-07-23 2010-01-28 Abbott Laboratories Vascular Enterprises Limited Balloon of a balloon catheter
EP2147695A1 (en) * 2008-07-23 2010-01-27 Abbott Laboratories Vascular Enterprises Limited Balloon of a balloon catheter
US8702745B2 (en) 2008-07-23 2014-04-22 Nicolas Degen Balloon of a balloon catheter
US9861797B2 (en) 2008-07-25 2018-01-09 Cook Medical Technologies Llc Balloon catheter and method for making same
WO2010011843A1 (en) * 2008-07-25 2010-01-28 Cook Incorporated Balloon catheter and method for making the same
US9067045B2 (en) 2008-07-25 2015-06-30 Cook Medical Technologies Llc Balloon catheter and method for making same
WO2010102796A2 (en) 2009-03-10 2010-09-16 Phenox Gmbh Device for applying active ingredients to the wall of a body vessel
DE102009011931A1 (en) 2009-03-10 2010-09-16 Innora Gmbh A device for application of active ingredients on the wall of a body vessel
DE202010017248U1 (en) 2009-04-24 2011-08-23 Eurocor Gmbh Shellac and paclitaxelbeschichtete catheter balloons
EP2243501A1 (en) 2009-04-24 2010-10-27 Eurocor Gmbh Shellac and paclitaxel coated catheter balloons
DE202009006632U1 (en) 2009-05-07 2009-07-16 Sellin, Lothar Coating of medical surfaces
US20100312182A1 (en) * 2009-06-04 2010-12-09 Nina Adden Structured drug-eluting balloon catheter
US10369256B2 (en) 2009-07-10 2019-08-06 Boston Scientific Scimed, Inc. Use of nanocrystals for drug delivery from a balloon
US10080821B2 (en) 2009-07-17 2018-09-25 Boston Scientific Scimed, Inc. Nucleation of drug delivery balloons to provide improved crystal size and density
WO2011046902A1 (en) * 2009-10-14 2011-04-21 Boston Scientific Scimed, Inc. Balloon catheter with shape memory sheath for delivery of therapeutic agent
WO2011044889A1 (en) 2009-10-16 2011-04-21 Hemoteq Ag Use of compositions to coat catheter balloons and coated catheter balloons
WO2011061295A1 (en) * 2009-11-19 2011-05-26 Blue Medical Devices Bv Narrow profile composition-releasing expandable medical balloon catheter
US9011896B2 (en) 2010-04-19 2015-04-21 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
US9770536B2 (en) 2010-04-19 2017-09-26 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
EP2886136A1 (en) 2010-04-19 2015-06-24 AngioScore, Inc. A Coated Angioplasty or Coronary Angioplasty Catheter
EP2886137A1 (en) 2010-04-19 2015-06-24 Angioscore Inc. A balloon catheter for angioplasty and coronary angioplasty and a method of manufacturing the balloon catheter
EP2735319A1 (en) 2010-04-19 2014-05-28 InnoRa Gmbh Improved formulations for drug-coated medical devices
WO2011131259A1 (en) 2010-04-19 2011-10-27 Innora Gmbh Improved coating formulations for scoring or cutting balloon catheters
US9072812B2 (en) 2010-04-19 2015-07-07 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
US9078951B2 (en) 2010-04-19 2015-07-14 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
US10314947B2 (en) 2010-04-19 2019-06-11 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
US9101684B2 (en) 2010-04-19 2015-08-11 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
EP2383000A1 (en) 2010-04-19 2011-11-02 InnoRa Gmbh Limus-coated medical devices
US9173977B2 (en) 2010-04-19 2015-11-03 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
EP2380604A1 (en) 2010-04-19 2011-10-26 InnoRa Gmbh Improved coating formulations for scoring or cutting balloon catheters
EP2380605A1 (en) 2010-04-19 2011-10-26 InnoRa Gmbh Improved formulations for drug-coated medical devices
WO2011131638A1 (en) 2010-04-19 2011-10-27 Innora Gmbh Improved coating formulations for scoring or cutting balloon catheters
WO2011131258A1 (en) 2010-04-19 2011-10-27 Innora Gmbh Improved formulations for drug-coated medical devices
WO2011131678A1 (en) 2010-04-19 2011-10-27 Innora Gmbh Limus-coated medical devices
US10383982B2 (en) 2010-04-19 2019-08-20 Angioscore, Inc. Coating formulations for scoring or cutting balloon catheters
US10046092B2 (en) 2010-04-19 2018-08-14 The Spectranetics Corporation Coating formulations for scoring or cutting balloon catheters
WO2011147407A2 (en) 2010-05-27 2011-12-01 Hemoteq Ag Balloon catheter coated with an anti-restenotic active ingredient and a molecular dispersion agent that promotes transport
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US9351756B2 (en) 2010-09-21 2016-05-31 Angioscore, Inc. Method and system for treating valve stenosis
US9364254B2 (en) 2010-09-21 2016-06-14 Angioscore, Inc. Method and system for treating valve stenosis
DE102011100122A1 (en) 2011-04-26 2012-10-31 Eurocor Gmbh Catheter balloon coated with rapamycin and shellac
WO2012146681A1 (en) 2011-04-26 2012-11-01 Eurocor Gmbh Catheter balloon coated with rapamycin and shellac
JP2014522272A (en) * 2011-05-26 2014-09-04 エーディーエヌ インターナショナル,エルエルシーAdn International,Llc Expandable device for tissue collection from airway digestive system body lumen
JP2018134419A (en) * 2011-05-26 2018-08-30 エーディーエヌ インターナショナル,エルエルシーAdn International,Llc Expandable device for tissue collection from an aerodigestive body lumen
EP3308719A3 (en) * 2011-05-26 2018-08-08 ADN International, LLC Expandable device for tissue collection from an aerodigestive body lumen
US9186129B2 (en) 2011-05-26 2015-11-17 Adn International, Llc Expandable device for tissue collection from an aerodigestive body lumen
EP2713890A4 (en) * 2011-05-26 2015-04-15 Adn International Llc Expandable device for tissue collection from an aerodigestive body lumen
EP2713890A1 (en) * 2011-05-26 2014-04-09 ADN International, LLC Expandable device for tissue collection from an aerodigestive body lumen
WO2013007273A1 (en) 2011-07-08 2013-01-17 Cardionovum Sp.Z.O.O. Balloon surface coating
WO2013007666A1 (en) 2011-07-08 2013-01-17 Cardionovum Sp.Z.O.O. Balloon surface coating
WO2013007653A1 (en) 2011-07-08 2013-01-17 Cardionovum Sp.Z.O.O. Balloon catheter with a sirolimus coated catheter balloon for controlled release of sirolimus
WO2013015941A1 (en) * 2011-07-26 2013-01-31 Medtronic Vascular Inc. Textured dilatation balloon
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
WO2013053809A1 (en) 2011-10-14 2013-04-18 Innora Gmbh Improved formulations for drug-coated medical devices
WO2013059272A1 (en) * 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Atherectomy positioning device
US9084627B2 (en) 2011-10-18 2015-07-21 Boston Scientific Scimed, Inc. Atherectomy positioning device
WO2013092416A1 (en) 2011-12-23 2013-06-27 Innora Gmbh Drug-coated medical devices
US9233191B2 (en) 2011-12-23 2016-01-12 Innora Gmbh Drug-coated medical devices
CN105943117A (en) * 2012-01-15 2016-09-21 小麦公司 Device and method for removing occlusions in a biological vessel
WO2013116560A1 (en) * 2012-01-31 2013-08-08 The Trustees Of Columbia University In The City Of New York Tissue sampling devices, methods, and systems
WO2014008875A1 (en) 2012-07-12 2014-01-16 Cardionovum Gmbh Catheter balloon, method for producing a coated catheter balloon and use of the pharmacological active ingredient
WO2014125465A2 (en) 2013-02-13 2014-08-21 Prendergast Thomas Patrick Method for loading dilatable catherer balloons and dilatation catheters obtained therefrom
WO2014177221A1 (en) 2013-05-02 2014-11-06 Cardionovum Gmbh Balloon surface coating
US10117668B2 (en) 2013-10-08 2018-11-06 The Spectranetics Corporation Balloon catheter with non-deployable stent having improved stability
WO2015089422A1 (en) * 2013-12-12 2015-06-18 Case Western Reserve University Device for collecting a biological sample
US20160317132A1 (en) * 2013-12-12 2016-11-03 Case Western Reserve University Device for collecting a biological sample
US10207083B2 (en) 2015-07-06 2019-02-19 Terumo Kabushiki Kaisha Balloon catheter and method for manufacturing balloon
EP3115077A1 (en) * 2015-07-06 2017-01-11 Terumo Kabushiki Kaisha Balloon catheter and method for manufacturing balloon

Similar Documents

Publication Publication Date Title
US6602265B2 (en) Tissue separation medical device and method
US5496267A (en) Asymmetric water jet atherectomy
US5135484A (en) Method of removing plaque from vessels
US5785675A (en) Thrombectomy device
US9445743B2 (en) Methods for generating luminal organ profiles using impedance
US6149581A (en) Device and method for access to the colon and small bowel of a patient
US6364840B1 (en) Acoustic imaging catheter and the like
CA2241274C (en) Endometrial tissue curette and method
US8679091B2 (en) Catheter
US5908435A (en) Expandable lumen device and method of use
US4651738A (en) Method and device for performing transluminal angioplasty
US8613721B2 (en) Delivery and administration of compositions using interventional catheters
EP1159982B1 (en) Wound treating device
US6361528B1 (en) Dynamically compliant catheter
CN102006905B (en) The inner circulation system for removing undesirable object system
US5817046A (en) Apparatus and method for isolated pelvic perfusion
US6953438B2 (en) Ultrasonic medical device
JP3136423B2 (en) Intravascular catheter porous
US5053008A (en) Intracardiac catheter
US6695858B1 (en) Medical device and methods for use
US6132378A (en) Cover for ultrasound probe
JP4271375B2 (en) Device and method for facilitating hemostasis of a biopsy conduit
US20030130681A1 (en) Disc shaped filter
EP0934727A1 (en) Rotary catheter for atherectomy system
AU709938B2 (en) Vascular incisor/dilator

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: CA